Bevacizumab/cetuximabPulmonary toxicities: 3 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2021年 / 1868卷 / 1期

关键词：

D O I：

10.1007/s40278-021-00570-5

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：113 / 113

相关论文

共 50 条

[1] Bevacizumab/dexamethasoneVarious toxicities: 3 case reports
[J]. Reactions Weekly, 2018, 1713 (1) : 64 - 64
[2] Bevacizumab/capecitabineVarious toxicities: 3 case reports
[J]. Reactions Weekly, 2014, 1524 (1) : 56 - 56
[3] Bevacizumab/carboplatin/paclitaxelVarious toxicities: 3 case reports
[J]. Reactions Weekly, 2019, 1763 (1) : 76 - 76
[4] Aflibercept/bevacizumab/ranibizumabVarious toxicities: 3 case reports
[J]. Reactions Weekly, 2021, 1839 (1) : 21 - 22
[5] Bevacizumab/eribulin/paclitaxelVarious toxicities: 3 case reports
[J]. Reactions Weekly, 2018, 1727 (1) : 65 - 65
[6] Bevacizumab/carmustineVarious toxicities: 8 case reports
[J]. Reactions Weekly, 2018, 1690 (1) : 43 - 43
[7] Bevacizumab/antineoplasticsVarious toxicities: 19 case reports
[J]. Reactions Weekly, 2013, 1447 (1) : 11 - 11
[8] Bevacizumab/paclitaxelVarious toxicities: 4 case reports
[J]. Reactions Weekly, 2021, 1844 (1) : 94 - 94
[9] Bevacizumab/dexamethasoneVarious toxicities: 6 case reports
[J]. Reactions Weekly, 2020, 1785 (1) : 112 - 112
[10] Bevacizumab/doxorubicinCardiac toxicities: 6 case reports
[J]. Reactions Weekly, 2012, 1405 (1) : 11 - 11

← 1 2 3 4 5 →